Controversies in Liver Transplantation

Schiff's Diseases of the Liver

Volumn , Issue , 2011, Pages 1183-1197

  Trotter, James F ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Donor by cardiac death; Expanded criteria donor; Liver allocation; Liver distribution; Liver transplantation; Living donor liver transplantation; Model for end stage liver disease

Indexed keywords

EID: 84873729651     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119950509.ch49     Document Type: Chapter

References (45)

1. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-70.
2. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001;7:567-80.
3. Coombes JM, Trotter JF. Development of the allocation system for deceased donor liver transplantation. Clin Med Res 2005;3:87-92.
4. Institute of Medicine Committee on Organ Procurement and Transplantation Policy. Organ Procurement and Transplantation: assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press, 1999:1-29.
5. Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004;S9:114-31.
6. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R; United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
7. UNOS Annual Report. http://www.ustransplant.org/annual?reports/ current/401?opo.htm. Accessed July 1, 2010.
8. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-13.
9. Freeman RB. The share 15 rule. In: Everson GT, Trotter JF. eds. Liver Transplantation Challenging Controversies and Topics. Totowa, NJ: Humana Press, 2009:91-101.
10. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004;291:1871-4.
11. Schaubel DE, Guidinger MK, Biggins SW, et al. Survival benefitbased deceased-donor liver allocation. Am J Transplant 2009;9: 970-81.
12. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996;24:1392-4.
13. Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant 2007;7:1624-8.
14. Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004;10:995-1000.
15. Xiol X, Gines P, Castells L, et al. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl 2009;15:300-5.
16. Lisman T, van Leeuwen Y, Adelmeijer J, et al. Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int 2008;28:1344-51.
17. Porte RJ, Lisman T, Tripodi A, Caldwell SH, Trotter JF; Coagulation in Liver Disease Study Group. The international normalized ratio (INR) in the MELD score: problems and solutions. Am J Transplant 2010;10:1349-53.
18. Heuman DM, Mihas AA, Habib A, et al. MELD-XI: a rational approach to sickest first liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl 2007;13:30-7.
19. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revisedmodel for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology 2011;140:1952-60.
20. Cholongitas E, Marelli L, Kerry A, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007;13:523-9.
21. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores - a systematic bias. Am J Transplant 2007;7:685-92.
22. Howard DH, Siminoff LA, McBride V, Lin M. Does quality improvement work? Evaluation of the Organ Donation Breakthrough Collaborative. Health Serv Res 2007;42:2160-73.
23. Steinbrook R. Organ donation after cardiac death. N Engl J Med 2007;357:209-13.
24. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006;244:555-62.
25. Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006;6:791-6.
26. Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery 2009;146:543-52.
27. de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transpl 2009;9:773-81.
28. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010;10:1003-19.
29. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-82.
30. Berg CL, Gillespie BW, Merion RM, et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007;133:1806-13.
31. Trotter JF, Wisniewski KA, Terrault NA, et al. Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology 2007;46:1476-84.
32. Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 2004;4:1302-7.
33. Freise CE, Gillespie BW, Koffron AJ, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant 2008;8: 2569-79.
34. Brown RS Jr, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003;348:818-25.
35. Ghobrial RM, Freise CE, Trotter JF, et al. Donormorbidity after living donation for liver transplantation. Gastroenterology 2008;135:468-76.
36. Guba M, Adcock L, MacLeod C, et al. Intraoperative 'no go' donor hepatectomies in living donor liver transplantation. Am J Transplant 2010;10:612-18.
37. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006;12:1485-8.
38. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-90.
39. Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation 2006;82:1653-7.
40. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8:419-25.
41. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007;13:391-9.
42. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-74.
43. Rodriguez-Luna H, Vargas HE, Moss A, et al. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 2005;5:2244-7.
44. Freeman RB Jr, Gish RG, Harper A, et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from theMELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006;12:S128-36.
45. Berg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009;9: 907-31.